Murai T, Kyoda N, Misaki T, Takada K, Sawada S, Machida T
Department of Dental Anesthesiology, Nihon University School of Dentistry, Tokyo, Japan.
Anesth Prog. 1995;42(3-4):135-8.
The effect of clonidine, an alpha 2-adrenoceptor agonist, on intravenous (IV) sedation with midazolam was studied. Subjects were eight healthy adults; IV sedation was performed twice on each subject. In the control (CO) group, midazolam alone was administered. In the clonidine (CL) group, the subjects were given about 5 micrograms/kg of clonidine orally 2 hr before the initiation of sedation with midazolam. The following parameters were determined: dose of midazolam, changes in vital signs, recovery time, amnesia, and side effects. The average sedating dose of midazolam was 0.078 and 0.043 mg/kg in the CO and CL groups, respectively. Recovery times determined by stabilometry were 150 and 120 min in the CO and CL groups, respectively. Based on these results, the combined use of clonidine can reduce the dose of midazolam and shorten the recovery time. It is suggested that clonidine may be useful in IV sedation with midazolam.
研究了α2-肾上腺素能受体激动剂可乐定对咪达唑仑静脉镇静的影响。受试者为8名健康成年人;每名受试者接受两次静脉镇静。在对照组(CO)中,仅给予咪达唑仑。在可乐定组(CL)中,受试者在开始用咪达唑仑镇静前2小时口服约5微克/千克可乐定。测定了以下参数:咪达唑仑剂量、生命体征变化、恢复时间、遗忘症和副作用。CO组和CL组咪达唑仑的平均镇静剂量分别为0.078和0.043毫克/千克。通过稳定测量法测定的恢复时间在CO组和CL组中分别为150分钟和120分钟。基于这些结果,可乐定的联合使用可降低咪达唑仑剂量并缩短恢复时间。提示可乐定可能有助于咪达唑仑静脉镇静。